Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening
-- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo.
- -- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo.
- -- By 2030, the early cancer detection screening opportunity is estimated to be US$6bn in Asia on an annual basis.
- The joint venture will be governed by a six-person board of directors composed of three directors from each side, with Prof.
- From prevention (CircleDNA) and early detection (Insighta) to treatment (ACT), our innovative approach promises to significantly raise the bar in healthcare."